ClinicalTrials.govpublic full text
Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
pik3ca-related overgrowth spectrum (pros), growth disorder, genetics, clinical trial, congenital malformations, overgrowth, pilot drug treatment trial, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032020
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.